Summary

Biophotonics Market Growth & Trends

The global biophotonics market size is expected to reach USD 134.83 billion by 2030, registering a CAGR of 10.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. The developments in optical technologies, increasing investigations by researchers, and mounting demand for early diagnosis are anticipated to drive the market growth over the forecast period. Biophotonics, being an evolving area of scientific research, has several applications due to its ability to harnesses light for comprehending the functioning of cells and tissue in living organisms. This further aids in better diagnosis of health problems.

The biophotonics market is projected to witness high growth during the forecast period, owing to its application in optical techniques while simultaneously preserving the integrity of the biological cells under surveillance. New laser microscopes are being developed which permit measurements of distinct molecules and tissues at exceptional resolutions.

Biophotonics also finds applications in numerous procedures including new laser microscopes, which allow exceptional specifications of molecules & single tissues, optical coherence tomography that assists in the minute imaging of biomaterials, and novel light-activated chemicals utilized for welding tissues through surgical procedures.

Considering the enormous application areas, it is becoming perplexing for the key market players to commercialize this technology. However, the market is confronted with a slow commercialization rate due to the low acceptance from end-users, price sensitivity, and concerns pertaining to the authenticity, quality, and reliability of the products.

Biophotonics Market Report Highlights

• The non-medical end-use segment is expected to emerge as the fastest-growing segment over the forecast period. The snowballing demand in the non-medical applications is predicted to offer several growth avenues over the next few years. The usage of biophotonics to examine tissues at macro and micro levels and diagnose diseases effectively is expected to be a key reason for its surging end-use applications.

• The analytics sensing segment accounted for the largest revenue share of around 23.2% in 2022. This is followed by the surface imaging segment, which is expected to exhibit a high market growth. In addition to this, the market is expected to observe growth with increasing adoption of this technology across various industries, such as biotechnology, therapeutics, agriculture, diagnostics, and life sciences R&D. Other impact rendering applications include environmental monitoring, food analysis, dosimetry, dentistry, and medical imaging utilizing endoscopy and Raman spectroscopy.

• Asia Pacific is expected to register the highest CAGR of 13.5% over the forecast period. Due to the augmented investment in R&D activities, coupled with the increasing prevalence of cancer, the market is expected to witness substantial growth. The increasing healthcare expenditure and rising government initiatives are expected to fuel the demand for the regional market.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Biophotonics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Application Value Chain Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunity Analysis
3.4. Biophotonics Market Analysis Tools
3.4.1. Application Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Biophotonics Market: Technology Estimates & Trend Analysis
4.1. Biophotonics Market: Key Takeaways
4.2. Biophotonics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. In-Vitro
4.3.1. In-vitro market estimates and forecasts, 2017 to 2030 (USD Million)
4.4. In-Vivo
4.4.1. In-vivo market estimates and forecasts, 2017 to 2030 (USD Million)
Chapter 5. Biophotonics Market: Application Estimates & Trend Analysis
5.1. Biophotonics Market: Key Takeaways
5.2. Biophotonics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. See-Through imaging
5.3.1. See-through imaging market estimates and forecasts, 2017 to 2030 (USD Million)
5.4. Microscopy
5.4.1. Microscopy market estimates and forecasts, 2017 to 2030 (USD Million)
5.5. Inside Imaging
5.5.1. Inside imaging market estimates and forecasts, 2017 to 2030 (USD Million)
5.6. Analytics sensing
5.6.1. Analytics sensing market estimates and forecasts, 2017 to 2030 (USD Million)
5.7. Light therapy
5.7.1. Light therapy market estimates and forecasts, 2017 to 2030 (USD Million)
5.8. Surface imaging
5.8.1. Surface imaging market estimates and forecasts, 2017 to 2030 (USD Million)
5.9. Biosensors
5.9.1. Biosensors market estimates and forecasts, 2017 to 2030 (USD Million)
Chapter 6. Biophotonics Market: End-use Estimates & Trend Analysis
6.1. Biophotonics Market: Key Takeaways
6.2. Biophotonics Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Tests and Components
6.3.1. Tests and components market estimates and forecasts, 2017 to 2030 (USD Million)
6.4. Medical Therapeutics
6.4.1. Medical therapeutics market estimates and forecasts, 2017 to 2030 (USD Million)
6.5. Medical Diagnostics
6.5.1. Medical diagnostics market estimates and forecasts, 2017 to 2030 (USD Million)
6.6. Non-medical Application
6.6.1. Non-medical application market estimates and forecasts, 2017 to 2030 (USD Million)
Chapter 7. Biophotonics Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Biophotonics Market by Region: Key Takeaway
7.3. North America
7.3.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.5.5. South Korea
7.5.5.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. Saudi Arabia
7.7.1.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.7.2. South Africa
7.7.2.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
7.7.3. United Arab Emirates (UAE)
7.7.3.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Affymetrix Inc. (Thermo Fisher Scientific Inc.)
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. BD (Becton, Dickinson and Company)
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. ZEISS Group
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Olympus Corporation
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Hamamatsu Photonics K.K
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Zecotek Photonics Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. IDEX
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. IPG Photonics Corporation
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. TOSHIBA CORPORATION
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Oxford Instruments
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. PerkinElmer Inc.
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives